Skip to main content

Table 2 Recent studies on isolation rates of NTM from human clinical specimens in different settings

From: Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014

Setting

Years

Prevalent NTM species

% of total isolates

Trend

Reference

Tuscany (Italy)

2004–2014

M. avium

41.5

Increase

This study

M. intracellulare

14.3

M. gordonae

11.6

England, Wales and Northern Ireland

1995–2006

M. avium-intracellulare

42.9

Increase

9

M. malmoense

13.7

M. kansasii

12.5

Scotland

2000–2010

M. avium complex

48.1

No clear trend

13

M. malmoense

17.7

M. abscessus

9.8

The Netherlands

2000–2006

M. avium complex

39.0

Increase

14

M. gordonae

14.1

M. kansasii

7.4

Croatia

2006–2010

M. gordonae

42.9

Increase

11

M. xenopi

15.5

M. fortuitum

11.5

Athens (Greece)

2007–2013

M. gordonae

13.9

No trend

20

M. avium

13.1

M. fortuitum

12.2

Virginia (USA)

2001–2009

M. avium complex

40.9

Increase

22

M. gordonae

28.7

M. abscessus

4.5

Oregon (USA)

2007–2012

M. avium-intracellulare

86

Increase

21

M. chelonae/abscessus

6

Shangai (China)

2008–2012

M. kansasii

45.0

Increase

23

M. intracellulare

20.8

M. chelonae/abscessus

14.9

Cheonan (Korea)

2005–2011

M. intracellulare

51.3

Increase

24

M. avium

14.7

M. kansasii

7.8

South Korea

2001–2011

M. avium complex

53

Increase

25

M. abscessus-massiliense

25

M. fortuitum

6